Boundless Bio BOLD
NASDAQ BOLD
$2.43 +0.12 (+5.19%)
At close: Oct 20, 2026 · 4:00 PM EDT

Boundless Bio (BOLD) Preferred Stock Liabilities (2023 - 2024)

Updated

Boundless Bio (BOLD) recorded Preferred Stock Liabilities of $247.62 million in Q1 2024, up 67.4% from $147.95 million a year earlier and unchanged from the prior quarter.

Analysis

Boundless Bio (BOLD) Preferred Stock Liabilities (2023 - 2024) Analysis & Trends

Starting with Q1 2023, Boundless Bio's Preferred Stock Liabilities history includes 5 quarters.

  • Per Business Quant, the preceding three quarters came in at $247.62 million (Q4 2023), $247.62 million (Q3 2023) and $247.62 million (Q2 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn -
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn -
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn -
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn -
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn -
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn -
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn -
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn -
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn -
10 Boundless Bio 53.99 Mn -18.61 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 247.62 Mn
Dec 31, 2023 247.62 Mn
Sep 30, 2023 247.62 Mn
Jun 30, 2023 247.62 Mn
Mar 31, 2023 147.95 Mn
API Access

Boundless Bio Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=BOLD&period=max&api_key=YOUR_API_KEY